Lung cancer (all types)

What changed: Lung cancer (all types)

Cancer page →

Every dated change on the records linked to Lung cancer (all types), newest first: approvals and regulatory steps on its medicines, trials that reported, guideline versions, milestones, and when this page itself was checked. Dates come from the records; none is inferred. Orientation, not medical advice.

Regulatory1Trial result2Milestone5This record1

FollowWatch this cancer and Saved shows what changed since you last looked.Follow by feed

September 2026 · 1

2026-09-17This recordLung cancer (all types)
Facts on this page last checked
When this page itself was last checked or edited.

2024 · 1

2024MilestoneTarlatamab
Tarlatamab: first targeted drug for small-cell lung cancer
A milestone in how this cancer is treated.

2020 · 1

2020Trial resultLung-MAP (SWOG S1400 and S1900)
Lung-MAP (SWOG S1400 and S1900) reported
Genotype-matched targeted arms (taselisib, palbociclib, AZD4547) closed for futility; nivolumab plus ipilimumab did not beat nivolumab (S1400I); ramucirumab plus pembrolizumab improved overall survival against standard care (S1800A).

March 2015 · 1

2015-03-04RegulatoryNivolumab
Nivolumab: approval (US)
Squamous NSCLC after platinum: first PD-1 in lung cancer

2015 · 1

2015MilestoneNivolumab
Nivolumab approved: immunotherapy enters lung cancer
A milestone in how this cancer is treated.

2011 · 2

2004 · 1

2004MilestoneGefitinib
EGFR mutations explain gefitinib responses
A milestone in how this cancer is treated.

1950 · 1

1950MilestoneLung cancer (all types)
Doll and Hill link smoking to lung cancer
A milestone in how this cancer is treated.